by admin | Jun 10, 2022 | Research
The latest double-blind, randomized controlled study shows that tocotrienol supplementation at 200mg twice a day for 12 months supports the improvement of early diabetic retinopathy by attenuating the progression of retinal microhemorrhage and diabetic macular edema...
by CM Lai | Jan 28, 2022 | Research, Tocotrienol
In a Phase II Clinical Trial recently published in the journal Nutrients, 12 months of supplementation of EVNol SupraBio™ exhibited a significant improvement in the conduction velocity of median and sural sensory nerves among type 2 diabetes patients. Diabetic...
by admin | Jun 18, 2021 | Research, Tocotrienol
A double-blind, randomized, placebo-controlled study has shown that a statistically significant percentage decrease in retinal microhemorrhages and diabetic macular edema could be achieved upon supplementation of EVNol SupraBio™ (encapsulated in softgels branded...
by admin | May 4, 2021 | Research, Tocotrienol
A pilot phase II clinical trial revealed that 8 weeks supplementation of EVNol SupraBio™ (encapsulated in softgels branded Tocovid SupraBio™) resulted in significant reduction in retinal hemorrhage in the right eye of diabetic retinopathy patients. Diabetic...
by admin | Jun 23, 2020 | Tocotrienol
Oral supplementation of EVNol SupraBio™ significantly improved nerve growth factor and nerve conduction velocities in the nerves of diabetic peripheral neuropathy (DPN) patients, as demonstrated in a Phase II study published in Nutrients (1). This multicenter,...
Recent Comments